Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.700
-0.060 (-2.17%)
Jun 5, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 505.16 million as of June 5, 2026. Its market cap has increased by 113.02% in one year.
Market Cap
505.16M
Enterprise Value
484.22M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 505.16M, an increase of 3,897.43%. That is a compound annual growth rate of 45.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 505.16M | 2.34% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.72B |
| PYC Therapeutics | 1.21B |
| Clarity Pharmaceuticals | 837.58M |
| Clinuvel Pharmaceuticals | 460.41M |
| Starpharma Holdings | 317.97M |
| Tetratherix | 299.52M |
| Orthocell | 212.36M |
| Recce Pharmaceuticals | 148.93M |